KR20190111167A - Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법 - Google Patents

Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법 Download PDF

Info

Publication number
KR20190111167A
KR20190111167A KR1020197028100A KR20197028100A KR20190111167A KR 20190111167 A KR20190111167 A KR 20190111167A KR 1020197028100 A KR1020197028100 A KR 1020197028100A KR 20197028100 A KR20197028100 A KR 20197028100A KR 20190111167 A KR20190111167 A KR 20190111167A
Authority
KR
South Korea
Prior art keywords
tissue
lgr6
composition
cell
lgr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020197028100A
Other languages
English (en)
Korean (ko)
Inventor
덴버 엠. 로크
Original Assignee
폴래러티티이, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56078499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20190111167(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 폴래러티티이, 인크. filed Critical 폴래러티티이, 인크.
Publication of KR20190111167A publication Critical patent/KR20190111167A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • A01N1/021—
    • A01N1/0221—
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/362—Skin, e.g. dermal papillae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Developmental Biology & Embryology (AREA)
KR1020197028100A 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법 Ceased KR20190111167A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462086526P 2014-12-02 2014-12-02
US62/086,526 2014-12-02
US14/954,335 US10926001B2 (en) 2014-12-02 2015-11-30 Methods related to minimally polarized functional units
US14/954,335 2015-11-30
PCT/US2015/063114 WO2016089825A1 (en) 2014-12-02 2015-12-01 Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020177017887A Division KR20170098844A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법

Publications (1)

Publication Number Publication Date
KR20190111167A true KR20190111167A (ko) 2019-10-01

Family

ID=56078499

Family Applications (5)

Application Number Title Priority Date Filing Date
KR1020197028100A Ceased KR20190111167A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법
KR1020187036619A Ceased KR20180136588A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법
KR1020217010934A Ceased KR20210043024A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법
KR1020187036618A Ceased KR20180136587A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법
KR1020177017887A Ceased KR20170098844A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법

Family Applications After (4)

Application Number Title Priority Date Filing Date
KR1020187036619A Ceased KR20180136588A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법
KR1020217010934A Ceased KR20210043024A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법
KR1020187036618A Ceased KR20180136587A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법
KR1020177017887A Ceased KR20170098844A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법

Country Status (21)

Country Link
US (7) US10926001B2 (https=)
EP (2) EP4438128A3 (https=)
JP (3) JP6791854B2 (https=)
KR (5) KR20190111167A (https=)
CN (1) CN107250348B (https=)
AU (3) AU2015355187C1 (https=)
BR (1) BR112017011808A2 (https=)
CA (1) CA2969707C (https=)
CO (1) CO2017006640A2 (https=)
CR (1) CR20170296A (https=)
EA (1) EA201791125A1 (https=)
GB (2) GB2569056B (https=)
HK (1) HK1250515A1 (https=)
IL (2) IL252613B (https=)
MX (2) MX2017007243A (https=)
MY (1) MY184931A (https=)
NZ (2) NZ733433A (https=)
PH (1) PH12017501009B1 (https=)
SG (2) SG11201704502RA (https=)
WO (1) WO2016089825A1 (https=)
ZA (1) ZA201703907B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201908271WA (en) * 2017-03-14 2019-10-30 Juno Therapeutics Inc Methods for cryogenic storage
AU2019212976A1 (en) * 2018-01-26 2020-07-23 Polarityte, Inc. Complex living interface-coordinated self-assembling materials (CLICSAM)
EP3743125A4 (en) * 2018-01-26 2022-03-02 Polarityte, Inc. BIOMATERIAL ACCELERATING SUBSTRATE WITH COMPOSITE INTERFACE
FR3082123B1 (fr) 2018-06-07 2020-10-16 Urgo Rech Innovation Et Developpement Pansement cellularise et son procede de fabrication
JP2024006681A (ja) * 2022-07-04 2024-01-17 学校法人近畿大学 生体材料
WO2025166131A1 (en) * 2024-02-01 2025-08-07 Board Of Regents, The University Of Texas System Compositions and methods for treating bone and muscle injuries

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040126881A1 (en) 2002-09-06 2004-07-01 Vincent Ronfard Fibrin cell supports and methods of use thereof
WO2006008009A2 (en) 2004-07-23 2006-01-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with leucine-rich repeat-containing gpcr 6 (lgr6)
US20060134074A1 (en) 2004-08-30 2006-06-22 Naughton Gail K Compositions and methods for promoting hair growth
EP1942957B1 (en) * 2005-10-27 2012-07-11 Coloplast A/S Biodegradable scaffold with ecm material
WO2008008009A1 (en) 2006-07-13 2008-01-17 St. Jude Medical Ab Medical information management in a patient information hub system
US8366723B2 (en) 2006-08-03 2013-02-05 Rassman Licensing, Llc Hair harvesting device and method with localized subsurface dermal fluid insertion
US7998737B2 (en) 2006-09-12 2011-08-16 Deutsches Krebsforschungszentrum Cell culture of keratinocytes under non-differentiating conditions
US9752124B2 (en) 2009-02-03 2017-09-05 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
GB201111244D0 (en) 2011-06-30 2011-08-17 Konink Nl Akademie Van Wetenschappen Knaw Culture media for stem cells
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
FI20095355A0 (fi) 2009-04-01 2009-04-01 Helsingin Yliopisto Regeneroituva aktiivinen matriisi ja sen käytöt
CN102498221A (zh) 2009-06-25 2012-06-13 株式会社资生堂 基于aff-4表达筛选抗白发剂的方法
US20110130711A1 (en) 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
JP6023049B2 (ja) 2010-06-30 2016-11-09 チェン，ジンシー 皮膚組織細胞の集合体の製造方法及びその用途
GB201106395D0 (en) 2011-04-14 2011-06-01 Hubrecht Inst Compounds
EP2771454B1 (en) 2011-10-27 2019-07-24 Universität Leipzig Method for deriving melanocytes from the hair follicle outer root sheath and preparation for grafting
JP6186997B2 (ja) 2012-08-07 2017-08-30 日油株式会社 塗布型帯電防止剤
US9655930B2 (en) 2012-10-01 2017-05-23 Aderans Research Institute, Inc. Compositions and methods for producing reconstituted skin
US20140106447A1 (en) 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells
LT2970890T (lt) 2013-03-14 2020-07-10 The Brigham And Women`S Hospital, Inc. Kompozicijos ir būdai, skirti epitelinių kamieninių ląstelių padauginimui ir kultivavimui
US9592257B2 (en) 2013-10-11 2017-03-14 MWV Cell, LLC Complete human skin organ generated from culture-expanded cells
CN103550828B (zh) * 2013-10-17 2016-01-27 中国科学院动物研究所 一种基于毛囊干细胞和硅凝胶敷料的皮肤重建方法
TWI548413B (zh) 2014-11-07 2016-09-11 國立臺灣大學 誘導毛囊新生的皮膚萃取物、組合物及其用途

Also Published As

Publication number Publication date
US12465669B2 (en) 2025-11-11
GB2569056B (en) 2020-01-01
CA2969707A1 (en) 2016-06-09
US20190046691A1 (en) 2019-02-14
JP2019088299A (ja) 2019-06-13
CA2969707C (en) 2019-08-20
EP3227431C0 (en) 2025-01-29
HK1245327A1 (zh) 2018-08-24
IL287488B2 (en) 2023-06-01
PH12017501009B1 (en) 2022-01-21
AU2019240603A1 (en) 2019-10-17
EP3227431A1 (en) 2017-10-11
ZA201703907B (en) 2023-03-29
BR112017011808A2 (pt) 2018-02-27
JP6791854B2 (ja) 2020-11-25
MX2017007243A (es) 2018-01-25
CN107250348A (zh) 2017-10-13
CN107250348B (zh) 2021-09-03
SG11201704502RA (en) 2017-06-29
US20180154044A1 (en) 2018-06-07
EP4438128A2 (en) 2024-10-02
US11596714B2 (en) 2023-03-07
NZ733433A (en) 2019-08-30
KR20210043024A (ko) 2021-04-20
AU2023202857A1 (en) 2023-05-25
IL252613B (en) 2021-12-01
GB2549872A (en) 2017-11-01
CO2017006640A2 (es) 2017-11-21
US11338060B2 (en) 2022-05-24
HK1250515A1 (zh) 2018-12-21
US20160151540A1 (en) 2016-06-02
GB2569056A (en) 2019-06-05
EP3227431B1 (en) 2025-01-29
AU2015355187B2 (en) 2019-10-03
JP2017538411A (ja) 2017-12-28
SG10201914058QA (en) 2020-03-30
KR20180136587A (ko) 2018-12-24
KR20170098844A (ko) 2017-08-30
US10926001B2 (en) 2021-02-23
CR20170296A (es) 2018-01-25
EA201791125A1 (ru) 2018-06-29
US11266765B2 (en) 2022-03-08
AU2019240603B2 (en) 2023-02-09
US20210322643A1 (en) 2021-10-21
US20230181797A1 (en) 2023-06-15
GB201710646D0 (en) 2017-08-16
EP3227431A4 (en) 2019-01-02
JP2020182880A (ja) 2020-11-12
US20220241464A1 (en) 2022-08-04
EP4438128A3 (en) 2024-11-13
IL252613A0 (en) 2017-07-31
MX2023001655A (es) 2023-04-24
US20180154043A1 (en) 2018-06-07
US11000629B2 (en) 2021-05-11
KR20180136588A (ko) 2018-12-24
AU2015355187C1 (en) 2020-02-20
AU2015355187A1 (en) 2017-06-29
IL287488A (en) 2021-12-01
NZ755260A (en) 2021-12-24
PH12017501009A1 (en) 2017-12-11
WO2016089825A1 (en) 2016-06-09
MY184931A (en) 2021-04-30
GB201902819D0 (en) 2019-04-17

Similar Documents

Publication Publication Date Title
US11338060B2 (en) Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using LGR4, LGR5 and LGR6 expressing epithelial stem cells
Moshaverinia et al. Application of stem cells derived from the periodontal ligament or gingival tissue sources for tendon tissue regeneration
ES2535087T3 (es) Estructura tridimensional de tejido
CN105517587B (zh) 伤口愈合与组织工程
Bellas et al. Sustained volume retention in vivo with adipocyte and lipoaspirate seeded silk scaffolds
KR101885122B1 (ko) 분화촉진 및 지속형 스페로이드 형태의 편도 유래 줄기세포의 배양 방법
JP2017538411A5 (https=)
Yang et al. Engineering human ventricular heart tissue based on macroporous iron oxide scaffolds
HK1245327B (en) Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells
OA19578A (en) Methods for development and use of minimally polarized function cell microaggregate units in tissue applications using LGR4, LGR5 and LGR6 expressing epithelial stem cells
OA19580A (en) Methods for development and use of minimally polarized function cell microaggregate units in tissue applications using LGR4, LGR5 and LGR6 expressing epithelial stem cells
Kim Enhancing functionalities of engineered skeletal muscle tissues by recreating natural environmental cues
JPWO2019093047A1 (ja) インビトロでの機能的な外分泌腺の製造方法、および、当該方法によって製造される外分泌腺

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20190925

Application number text: 1020177017887

Filing date: 20170628

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20191224

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20200918

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20191224

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20200918

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20200504

Comment text: Amendment to Specification, etc.

E801 Decision on dismissal of amendment
PE0801 Dismissal of amendment

Patent event code: PE08012E01D

Comment text: Decision on Dismissal of Amendment

Patent event date: 20210114

Patent event code: PE08011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20201216

Patent event code: PE08011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20200504

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20210115

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20191224

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I